Trial Profile
Aripiprazole for clozapine associated medical morbidity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Clozapine
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- 04 Sep 2012 Results published in the Acta Psychiatrica Scandinavica.
- 01 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jul 2008 The expected completion date for this trial is now 1 Oct 2009, as reported by ClinicalTrials.gov.